X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs CADILA HEALTHCARE - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH CADILA HEALTHCARE STERLING BIOTECH/
CADILA HEALTHCARE
 
P/E (TTM) x -1.7 32.3 - View Chart
P/BV x 0.1 6.0 1.1% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 STERLING BIOTECH   CADILA HEALTHCARE
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
CADILA HEALTHCARE
Mar-17
STERLING BIOTECH/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs11460 2.3%   
Low Rs3305 1.1%   
Sales per share (Unadj.) Rs26.892.1 29.1%  
Earnings per share (Unadj.) Rs-15.014.8 -100.9%  
Cash flow per share (Unadj.) Rs-5.518.5 -29.6%  
Dividends per share (Unadj.) Rs03.20 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs54.968.0 80.7%  
Shares outstanding (eoy) m267.871,023.74 26.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.2 6.2%   
Avg P/E ratio x-0.525.8 -1.8%  
P/CF ratio (eoy) x-1.320.7 -6.1%  
Price / Book Value ratio x0.15.6 2.3%  
Dividend payout %021.6 0.0%   
Avg Mkt Cap Rs m1,862391,581 0.5%   
No. of employees `0001.416.9 8.0%   
Total wages/salary Rs m54715,002 3.6%   
Avg. sales/employee Rs Th5,303.35,594.5 94.8%   
Avg. wages/employee Rs Th403.8890.1 45.4%   
Avg. net profit/employee Rs Th-2,959.0899.9 -328.8%   
INCOME DATA
Net Sales Rs m7,18194,295 7.6%  
Other income Rs m431,286 3.3%   
Total revenues Rs m7,22395,581 7.6%   
Gross profit Rs m94719,036 5.0%  
Depreciation Rs m2,5433,750 67.8%   
Interest Rs m4,377450 972.7%   
Profit before tax Rs m-5,93116,122 -36.8%   
Minority Interest Rs m0338 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3 0.0%   
Tax Rs m-1,9241,289 -149.3%   
Profit after tax Rs m-4,00715,168 -26.4%  
Gross profit margin %13.220.2 65.3%  
Effective tax rate %32.48.0 405.8%   
Net profit margin %-55.816.1 -346.9%  
BALANCE SHEET DATA
Current assets Rs m14,33560,223 23.8%   
Current liabilities Rs m49,80953,058 93.9%   
Net working cap to sales %-494.07.6 -6,501.6%  
Current ratio x0.31.1 25.4%  
Inventory Days Days40370 577.7%  
Debtors Days Days17188 193.6%  
Net fixed assets Rs m55,43272,984 76.0%   
Share capital Rs m2681,024 26.2%   
"Free" reserves Rs m13,93568,576 20.3%   
Net worth Rs m14,70169,600 21.1%   
Long term debt Rs m9,47824,684 38.4%   
Total assets Rs m73,988152,207 48.6%  
Interest coverage x-0.436.8 -1.0%   
Debt to equity ratio x0.60.4 181.8%  
Sales to assets ratio x0.10.6 15.7%   
Return on assets %0.510.3 4.9%  
Return on equity %-27.321.8 -125.1%  
Return on capital %-6.417.9 -35.8%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Exports (fob) Rs m1,860NA-   
Imports (cif) Rs m12NA-   
Fx inflow Rs m1,86021,280 8.7%   
Fx outflow Rs m2510,874 0.2%   
Net fx Rs m1,83510,406 17.6%   
CASH FLOW
From Operations Rs m1,71913,495 12.7%  
From Investments Rs m-3,148-29,103 10.8%  
From Financial Activity Rs m1,42623,158 6.2%  
Net Cashflow Rs m-37,556 -0.0%  

Share Holding

Indian Promoters % 33.9 74.8 45.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 8.3 -  
FIIs % 9.9 5.9 167.8%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 11.0 357.3%  
Shareholders   21,482 44,069 48.7%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   UNICHEM LAB  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SUN PHARMA  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Firm; IT Stocks Gain(09:30 am)

Asian stocks were relatively subdued in the early trade today, with most regional indices hovering around the flat line following the softer lead stateside.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Feb 21, 2018 11:31 AM

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS